Scienture Holdings - 16 Year Stock Price History | SCNX

Historical daily share price chart and data for Scienture Holdings since 2009 adjusted for splits and dividends. The latest closing stock price for Scienture Holdings as of July 16, 2025 is 2.05.
  • The all-time high Scienture Holdings stock closing price was 50460.60 on June 25, 2009.
  • The Scienture Holdings 52-week high stock price is 21.00, which is 924.4% above the current share price.
  • The Scienture Holdings 52-week low stock price is 0.69, which is 66.3% below the current share price.
  • The average Scienture Holdings stock price for the last 52 weeks is 4.68.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Scienture Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.9861 6.0034 6.0500 0.7818 2.0500 -66.12%
2024 7.6647 3.3329 21.1186 2.5604 6.0500 86.90%
2023 4.0829 2.7566 10.1918 2.4305 3.2371 -13.95%
2022 13.6847 24.5761 25.8843 2.7118 3.7621 -82.94%
2021 45.2874 50.5539 73.3545 22.0531 22.0531 -55.39%
2020 56.5213 70.0841 92.5109 38.3126 49.4325 -19.85%
2019 50.6651 22.3540 83.5403 20.2963 61.6740 266.67%
2018 25.9500 19.0629 56.0672 12.3348 16.8202 -33.33%
2017 29.3332 36.1522 47.6572 12.3348 25.2303 -2.17%
2016 45.9741 64.4773 70.0841 25.7910 25.7910 -58.18%
2015 64.7121 92.5109 98.1177 28.0336 61.6740 -35.29%
2014 111.3517 123.3480 448.5390 33.6404 95.3143 -19.05%
2013 51.7409 28.0337 151.3820 22.4269 117.7410 320.00%
2012 49.6012 61.6741 100.9210 16.8202 28.0337 -37.50%
2011 262.4072 465.3590 1009.2100 22.4269 44.8539 -90.36%
2010 2348.1910 7569.1000 8858.6400 465.3590 465.3590 -92.91%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.022B $0.000B
Scienture Holdings Inc., through its wholly owned subsidiaries, Scienture and Integra Pharma Solutions, LLC, is a comprehensive pharmaceutical product company focused on providing enhanced value to patients, physicians and caregivers by offering novel specialty products to satisfy unmet market needs. Scienture Holdings Inc., formerly known as TRxADE Health Inc., is based in TAMPA, FL.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.266B 28.24
Zoetis (ZTS) United States $68.055B 25.39
Takeda Pharmaceutical (TAK) Japan $46.933B 9.34
Daiichi Sankyo, - (DSNKY) Japan $43.096B 22.09
BeOne Medicines - (ONC) Cayman Islands $29.559B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.954B 0.00
Summit Therapeutics (SMMT) United States $18.091B 0.00
Merck (MKKGY) Germany $16.498B 12.09
Shionogi (SGIOY) Japan $14.172B 14.20
United Therapeutics (UTHR) United States $13.227B 11.70
Neurocrine Biosciences (NBIX) United States $12.988B 44.49
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.239B 0.00
Stevanato Group S.p.A (STVN) Italy $7.753B 47.41
Corcept Therapeutics (CORT) United States $7.573B 61.56
Madrigal Pharmaceuticals (MDGL) United States $6.908B 0.00
Grifols, S.A (GRFS) Spain $6.717B 0.00
Ionis Pharmaceuticals (IONS) United States $6.685B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.265B 16.01
Soleno Therapeutics (SLNO) United States $4.212B 0.00
Hypermarcas (HYPMY) Brazil $3.167B 20.83
Crinetics Pharmaceuticals (CRNX) United States $2.980B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.592B 14.02
Catalyst Pharmaceuticals (CPRX) United States $2.555B 8.95
NewAmsterdam Pharma (NAMS) Netherlands $2.360B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.014B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.825B 0.00
Ocular Therapeutix (OCUL) United States $1.767B 0.00
ARS Pharmaceuticals (SPRY) United States $1.725B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
Guardian Pharmacy Services (GRDN) United States $1.301B 0.00
Harrow (HROW) United States $1.261B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.215B 24.30
Ardelyx (ARDX) United States $1.077B 0.00
Enliven Therapeutics (ELVN) United States $1.062B 0.00
Collegium Pharmaceutical (COLL) United States $1.028B 5.55
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.004B 0.00
ProKidney (PROK) United States $0.986B 0.00
Verve Therapeutics (VERV) United States $0.982B 0.00
Dyne Therapeutics (DYN) United States $0.941B 0.00
Xeris Biopharma Holdings (XERS) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.779B 0.00
KalVista Pharmaceuticals (KALV) United States $0.758B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.724B 0.00
Zevra Therapeutics (ZVRA) United States $0.699B 0.00
Xencor (XNCR) United States $0.601B 0.00
Relay Therapeutics (RLAY) United States $0.600B 0.00
USANA Health Sciences (USNA) United States $0.583B 12.68
Theravance Biopharma (TBPH) United States $0.577B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Bioventus (BVS) United States $0.542B 13.75
Oruka Therapeutics (ORKA) United States $0.534B 0.00
Organogenesis (ORGO) United States $0.511B 0.00
Siga Technologies (SIGA) United States $0.479B 10.00
Tourmaline Bio (TRML) United States $0.477B 0.00
Aquestive Therapeutics (AQST) United States $0.399B 0.00
Savara (SVRA) United States $0.396B 0.00
Altimmune (ALT) United States $0.339B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.13
Tonix Pharmaceuticals Holding (TNXP) United States $0.325B 0.00
Heron Therapeutics (HRTX) United States $0.311B 0.00
AleAnna (ANNA) United States $0.305B 0.00
Aldeyra Therapeutics (ALDX) United States $0.298B 0.00
Nektar Therapeutics (NKTR) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 25.34
Nanobiotix S.A (NBTX) France $0.251B 0.00
OmniAb (OABI) United States $0.238B 0.00
Esperion Therapeutics (ESPR) United States $0.224B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.194B 0.00
4D Molecular Therapeutics (FDMT) United States $0.193B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Journey Medical (DERM) United States $0.163B 0.00
Liminatus Pharma (LIMN) United States $0.145B 0.00
Avita Medical (RCEL) United States $0.141B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Lyell Immunopharma (LYEL) United States $0.135B 0.00
Inhibikase Therapeutics (IKT) United States $0.134B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.111B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.73
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.099B 0.00
Jupiter Neurosciences (JUNS) United States $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Metagenomi (MGX) United States $0.078B 0.00
Rafael Holdings (RFL) United States $0.077B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.074B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.066B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Klotho Neurosciences (KLTO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.058B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.89
Avalo Therapeutics (AVTX) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Vivos Therapeutics (VVOS) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
BioVie (BIVI) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.21
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00